Ldl-Ex Seiken Assay Kit
System, Test, Low Density, Lipoprotein. 510(k) K043264, from Denka Seiken Co., Ltd. (Gosen-Shi, Niigata, JP). Product code MRR, class 1.
As of Nov 19, 2026, K043264 is an FDA 510(k) held by Denka Seiken Co., Ltd., substantially equivalent on Jan 26, 2005 after 63 days, with no recalls tied to it in FDA's recall database.
- Review time: 63 days
- Recalls: 0
The LDL-EX SEIKEN Assay Kit is an in vitro diagnostic test for the quantitative determination of low-density lipoprotein cholesterol (LDL-C) in human serum and heparinized- or EDTA-plasma. Lipoprotein measurements are used in the diagnosis and treatment of lipid disorders (such as diabetes mellitus, atherosclerosis and various liver and renal diseases).
- N-Geneous Ldl Cholesterol Reagent, N-Geneous Ldl Cholesterol Calibrator, Genzyme Ldl Cholesterol Control SetK971573 · Genzyme Corp. · Jun 18, 1997
- Atellica® CH HDL Cholesterol (HDLC)& Atellica® CH LDL Cholesterol (LDLC)K241800 · Siemens Healthcare Diagnostics, Inc. · Jul 26, 2024
- AXINON® LDL-p Test SystemK210801 · Numares AG · Jul 19, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 24, 2004
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1475
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files